HSD17B13 anticorps (AA 1-200)
Aperçu rapide pour HSD17B13 anticorps (AA 1-200) (ABIN7858520)
Antigène
Voir toutes HSD17B13 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
Clone
-
-
Épitope
- AA 1-200
-
Fonction
- HSD17B13 / Hydroxysteroid 17-beta dehydrogenase 13 (NAFLD / NASH Marker) Antibody
-
Specificité
- Hydroxysteroid 17-beta dehydrogenase 13 (HSD17B13) is an engyme in the liver that is associated with lipid droplets. It is encoded by the HSD17B13 gene in humans. HSD17B13 levels increase in patients with non-alcoholic fatty liver disease (NAFLD) and can enhance lipogenesis. However, some studies have shown that loss-of-function variants in HSD17B13 may protect against the progression of NAFLD to non-alcoholic steatohepatitis, fibrosis, and hepatocellular carcinoma.
-
Purification
- 200ug/ml of Ab Purified from Bioreactor Concentrate by Protein A/G.
-
Immunogène
- Recombinant fragment (around aa1-200) of human HSD17B13 protein (exact sequence is proprietary)
-
Isotype
- IgG2b, kappa
-
-
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Concentration
- 1.0 mg/mL
-
Buffer
- Prepared in 10 mM PBS
-
Agent conservateur
- Azide free
-
Stock
- -20 °C,-80 °C
-
Stockage commentaire
- Antibody with azide - store at 2 to 8°C. Antibody without azide - store at -20 to -80°C. Antibody is stable for 24 months. Non-hazardous. No MSDS required.
-
Date de péremption
- 24 months
-
-
- HSD17B13 (Hydroxysteroid (17-Beta) Dehydrogenase 13 (HSD17B13))
-
Autre désignation
- HSD17B13
-
Sujet
-
7-beta hydroxysteroid dehydrogenase, 17-beta-HSD 13, hepatic retinol/retinal dehydrogenase, short chain dehydrogenase/reductase family 16C member 3, short-chain dehydrogenase/reductase 9
Human liver, ovary, kidney, brain or bone marrow.
-
Poids moléculaire
- 30kDa
-
ID gène
- 345275
-
UniProt
- Q7Z5P4
Antigène
-